Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. (Q51609262)

8 April 2018

http://europepmc.org/abstract/MED/27469595

title

Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma. (English)

1 reference

8 April 2018

http://europepmc.org/abstract/MED/27469595

main subject

invasive lobular carcinoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Cheol Keun Park

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Woo Hee Jung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

28 July 2016

1 reference

8 April 2018

http://europepmc.org/abstract/MED/27469595

number of pages

15

1 reference

based on heuristic

inferred from page(s)

published in

Breast Cancer Research and Treatment

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

55-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-016-3929-2

11 June 2020

exact match

0 references

cites work

Trends in incidence rates of invasive lobular and ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Clinical characteristics of different histologic types of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

The cytokeratin profile of medullary carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Cancer associated fibroblasts in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

The stroma reaction myofibroblast: a key player in the control of tumor cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

PDGF receptors as cancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Functional subsets of mesenchymal cell types in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Stromal cells in tumor microenvironment and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Human breast carcinoma desmoplasia is PDGF initiated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Fibroblast activation protein-α promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Fibroblast heterogeneity in the cancer wound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-016-3929-2

10.1007/S10549-016-3929-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469595%20AND%20SRC:MED&resulttype=core&format=json

release_mogllx4fjvef7jommmytentfoe

11 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mogllx4fjvef7jommmytentfoe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference